World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
12919
World Ranking
2793
National Ranking
248

Ian Sabroe publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ian Sabroe sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 233 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ian Sabroe D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ian Sabroe sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ian Sabroe is affiliated with the University of Sheffield in the United Kingdom. Their research primarily spans the field of Medicine, with a focused interest in Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Immunology, Infectious Diseases, and Atomic and Molecular Physics, and Optics.

The scientist's work covers diverse topics, including:

  • Pulmonary Hypertension Research and Treatments
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • COVID-19 Clinical Research Studies
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Cardiovascular Function and Risk Factors
  • Inflammasome and immune disorders
  • Vascular Anomalies and Treatments

Frequent publication venues include:

  • European Respiratory Journal (3 publications)
  • ERJ Open Research (3 publications)
  • Clinical & Experimental Immunology (3 publications)
  • Nature Communications (2 publications)
  • Pulmonary Circulation (2 publications)

Among recent papers, notable titles include:

  • "A Bittersweet Response to Infection in Diabetes; Targeting Neutrophils to Modify Inflammation and Improve Host Immunity," 2021, Frontiers in Immunology
  • "Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension," 2020, European Respiratory Journal
  • "Diagnostic accuracy of CT pulmonary angiography in suspected pulmonary hypertension," 2020, European Radiology
  • "Lung MRI with hyperpolarised gases: current & future clinical perspectives," 2021, British Journal of Radiology
  • "EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study," 2020, European Respiratory Journal

The scientist has collaborated frequently with several coauthors, including:

  • David G. Kiely (12 collaborations)
  • Robin Condliffe (12 collaborations)
  • A. A. Roger Thompson (10 collaborations)
  • Athanasios Charalampopoulos (9 collaborations)
  • Charlie Elliot (8 collaborations)

Best Publications

  • Toll-Like Receptor (TLR)2 and TLR4 in Human Peripheral Blood Granulocytes: A Critical Role for Monocytes in Leukocyte Lipopolysaccharide Responses

    Ian Sabroe;Elizabeth C. Jones;Lynne R. Usher;Moira K. B. Whyte

  • Selective Roles for Toll-Like Receptor (TLR)2 and TLR4 in the Regulation of Neutrophil Activation and Life Span

    Ian Sabroe;Lynne R. Prince;Elizabeth C. Jones;Malcolm J. Horsburgh

  • Eotaxin (CCL11) and Eotaxin-2 (CCL24) Induce Recruitment of Eosinophils, Basophils, Neutrophils, and Macrophages As Well As Features of Early- and Late-Phase Allergic Reactions Following Cutaneous Injection in Human Atopic and Nonatopic Volunteers

    Andrew Menzies-Gow;Sun Ying;Ian Sabroe;Victoria L. Stubbs

  • Toll-Like Receptors in Health and Disease: Complex Questions Remain

    Ian Sabroe;Robert C. Read;Moira K. B. Whyte;David H. Dockrell

  • The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy.

    James E. Pease;Ian Sabroe

  • The role of TLRs in neutrophil activation.

    Lynne R Prince;Moira K Whyte;Ian Sabroe;Lisa C Parker

  • Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity.

    L. C. Parker;L. R. Prince;I. Sabroe

  • The role of TLR activation in inflammation

    I Sabroe;L C Parker;S K Dower;M K B Whyte

  • Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease.

    Andrei E. Medvedev;Ian Sabroe;Jeffrey D. Hasday;Stefanie N. Vogel

  • A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3 POTENT INHIBITION OF EOSINOPHIL FUNCTION AND CCR3-MEDIATED HIV-1 ENTRY

    I Sabroe;MJ Peck;BJ Van Keulen;A Jorritsma

  • The Role of Toll-Like Receptors in the Regulation of Neutrophil Migration, Activation, and Apoptosis

    Ian Sabroe;Steven K. Dower;Moira K. B. Whyte

  • Invited review: Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease

    Andrei E. Medvedev;Ian Sabroe;Jeffrey D. Hasday;Stefanie N. Vogel

  • The expression and roles of Toll-like receptors in the biology of the human neutrophil

    Lisa C. Parker;Moira K. B. Whyte;Steven K. Dower;Ian Sabroe

  • Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice

    Sarah R. Walmsley;Edwin R. Chilvers;Alfred A. Thompson;Kathryn Vaughan

  • Differential Regulation of Eosinophil Chemokine Signaling Via CCR3 and Non-CCR3 Pathways

    Ian Sabroe;Adele Hartnell;Louise A. Jopling;Sandra Bel

  • Eotaxin is specifically cleaved by hookworm metalloproteases preventing its action in vitro and in vivo.

    Fiona J. Culley;Alan Brown;Dolores M. Conroy;Ian Sabroe

  • Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells.

    Lisa C. Parker;Moira K. B. Whyte;Stefanie N. Vogel;Steven K. Dower

  • Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor.

    Jon R. Ward;Lynne Bingle;Heather M. Judge;Simon B. Brown

  • Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish.

    A. A. Roger Thompson;Philip M. Elks;Helen M. Marriott;Suttida Eamsamarng

  • TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation.

    Emmet E. McGrath;Helen M. Marriott;Allan Lawrie;Sheila E. Francis

Frequent Co-Authors

Moira K. B. Whyte
Moira K. B. Whyte University of Edinburgh
David H. Dockrell
David H. Dockrell University of Edinburgh
Steven K. Dower
Steven K. Dower CSL (Australia)
James E. Pease
James E. Pease Imperial College London
Stephen A. Renshaw
Stephen A. Renshaw University of Sheffield
Timothy J. Williams
Timothy J. Williams National Institutes of Health
Robert F. Storey
Robert F. Storey University of Sheffield
Clare M. Lloyd
Clare M. Lloyd Imperial College London
Stephen J. Till
Stephen J. Till King's College London
Edwin R. Chilvers
Edwin R. Chilvers Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their education in immunology-related healthcare fields, exploring online degree options can be both convenient and cost-effective. Many professionals consider transitioning into specialized nursing roles that complement their immunology knowledge, such as psychiatric mental health nurse practitioners. Programs offering affordable PMHNP programs enable students to gain advanced skills without excessive financial burden.

Understanding potential earnings is also crucial when exploring career pathways. Doctor of Nursing Practice (DNP) nurses, for example, can expect competitive salaries that vary by location. Interested candidates should review data on how much do DNPs make to make informed decisions about their career moves.

For nurse practitioners already certified as Family Nurse Practitioners (FNPs), transitioning to more specialized roles, such as acute care, opens new career opportunities. Guidance on FNP to acute care NP pathways can help navigate certification and training requirements.

Additionally, accelerated RN to NP programs offer an efficient route for registered nurses aiming to expand their clinical expertise and advance their careers. Reviewing the best available options in accelerated RN to NP programs can streamline this transition.

Best Scientists Citing Ian Sabroe

Trending Scientists

Recently Published Articles